Use of recombinant activated factor VII in a Jehovah's Witness patient

American Journal of Emergency Medicine

Volumn 25, Issue 9, 2007, Pages 1085.e1-1085.e2

  Hsieh, Albert ^a   Cheong, Izham ^b,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b Dubbo Base Hospital   (Australia)

^c University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; VITAMIN K GROUP;

AGED; ARTICLE; CASE REPORT; GASTROINTESTINAL HEMORRHAGE; HUMAN; JEHOVAH'S WITNESS; MALE; MYELODYSPLASTIC SYNDROME; OROPHARYNX CARCINOMA; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RECTUM HEMORRHAGE;

EID: 36049029162     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2007.03.007     Document Type: Article

References (9)

1. Marsh J.C.W., and Bevan D.H. Haematological care of the Jehovah's Witness patient. [see comment]. Br J Haematol 119 (2002) 25-37
2. Gannon C.J., and Napolitano L.M. Severe anemia after gastrointestinal hemorrhage in a Jehovah's Witness: new treatment strategies. [see comment]. Crit Care Med 30 (2002) 1893-1895
3. Veneri D., and Franchini M. Successful treatment of intestinal hemorrhage in a Jehovah's Witness patient. Am J Hematol 79 (2005) 344-345
4. Haan J., and Scalea T. A Jehovah's Witness with complex abdominal trauma and coagulopathy: use of factor VII and a review of the literature. Am Surg 71 (2005) 414-415
5. Allison G., and Feeney C. Successful use of a polymerized hemoglobin blood substitute in a critically anemic Jehovah's Witness. South Med J 97 (2004) 1257-1258
6. Gohel M.S., Bulbulia R.A., Slim F.J., Poskitt K.R., and Whyman M.R. How to approach major surgery where patients refuse blood transfusion (including Jehovah's Witnesses). Ann R Coll Surg Engl 87 (2005) 3-14
7. Virchis A., Hughes C., and Berney S. Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopenia. Hematol J 5 (2004) 281-282
8. Tanaka K.A., Waly A.A., Cooper W.A., and Levy J.H. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven). Anesthesiology 98 (2003) 1513-1515
9. COAGULATION FACTOR VIIA. In Klasco RK, editor. DRUGDEX System. Greenwood Village, Colorado: Thomson Micromedex. MICROMEDEX (R) Healthcare Series. Retrieved January 9, 2007 from http://www.micromedex.com/index.html.